SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against OvaScience, Inc. and Strongly Encourages Investors to Contact the Firm

Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by OvaScience, Inc. (“OvaScience” or the “Company”) (Nasdaq: OVAS). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased shares of OvaScience during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

This investigation will focus on whether the Company issued misleading statements and omitted material information due to OvaScience’s failure to disclose that the OvaScience’s AUGMENT procedure did not attain a substantial success rate of clinical pregnancies compared to former rates attained without OvaScience’s AUGMENT procedure.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160126006795/en/